JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1993) 138, 1-5    DOI: 10.1677/joe.0.1380001
© 1993 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eggo, M. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Eggo, M. C.

Protein kinase C in the thyroid

M. C. Eggo

Introduction: Protein kinase activation is pivotal in the signalling mechanism of many hormones, growth factors and neurotransmitters. Kinases are classified according to their substrate amino acids, i.e. serine/threonine specific or tyrosine specific. The regulators of serine/threonine-specific kinases include cyclic AMP (cAMP), cyclic GMP, Ca2+/calmodulin and Ca2+/phospholipid/diacylglycerol. Tyrosine-specific kinases are integral parts of the cytoplasmic domains of the receptors for many growth factors and are activated by binding of ligand.

An unavoidable conclusion from any study of cell signalling by kinases is that signals cannot be considered in isolation. Each signalling event ramifies into other signalling pathways. For example, the activity of adenylate cyclase which produces cAMP, and phosphodiesterases which hydrolyse cAMP, can be modulated independently by other signalling systems through their kinases (for review see Clemens et al. 1992). This commentary will review the effects of signalling through the Ca2+/phospholipid/diacylglycerol-dependent kinase (protein kinase




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
S. Korem, M. B. Resnick, and Z. Kraiem
Similar and Divergent Patterns in the Regulation of Matrix Metalloproteinase-1 (MMP-1) and Tissue Inhibitor of MMP-1 Gene Expression in Benign and Malignant Human Thyroid Cells
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3322 - 3327.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Heinrich and Z. Kraiem
The Protein Kinase A Pathway Inhibits c-jun and c-fos Protooncogene Expression Induced by the Protein Kinase C and Tyrosine Kinase Pathways in Cultured Human Thyroid Follicles
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1839 - 1844.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Society for Endocrinology.